ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Al-Samkari, H
  • Galacteros, F
  • Glenthoj, A
  • Rothman, JA
  • Andres, O
  • Grace, RF
  • Arias, Morado M
  • Layton, DM
  • Onodera, K
  • Verhovsek, Madeleine
  • Barcellini, W
  • Judge, MP
  • Beynon, V
  • Xu, E
  • Hawkins, P
  • Zagadailov, E
  • Gheuens, S
  • van Beers, EJ

publication date

  • September 1, 2021